Reduce the rate of CV death, MI, & stroke in patients w/ acute coronary syndrome (ACS) or history of MI. For at least the 1st 12 mth following ACS, it is superior to clopidogrel. Reduces the rate of stent thrombosis in patients who have been stented for treatment of ACS.
Dosage/Direction for Use
Initially 180 mg oral loading dose following an ACS event. Continue w/ 90 mg twice daily during the 1st yr after an ACS event. After 1 yr, administer 60 mg twice daily.
Sign Out
